MedDataX Logo

Interrupted Versus Continuous Subcuticular Skin Suturing in Elective Cesarean Section.

NCT ID: NCT03120806

Last Updated: 2021-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

169 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-16

Study Completion Date

2017-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Non-diabetic pregnant women who undergo elective CS will be randomized into two groups: group I included women who has their skin closed with subcuticular interrupted mattress suture using non-absorbable polypropylene, and group II included women who has their skin closed with subcuticular continous suture using the same suture material

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Non-diabetic pregnant women who undergo elective CS will be randomized into two groups: group I included women who had their skin closed with subcuticular interrupted mattress suture using non-absorbable polypropylene, and group II included women who had their skin closed with subcuticular continous suture using the same suture material.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cesarean Section Wound

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

continous subcuticular

skin closed with continous subcuticular mattress suture using non-absorbable polypropylene

Group Type ACTIVE_COMPARATOR

continuous subcuticular skin closure

Intervention Type PROCEDURE

skin is closed with continuous subcuticular sutures using non-absorbable polypropylene after elective cesarean section

Interrupted subcuticular

skin closed with interrupted subcuticular mattress suture using non-absorbable polypropylene

Group Type ACTIVE_COMPARATOR

Interrupted subcuticular skin closure

Intervention Type PROCEDURE

skin is closed with interrupted mattress subcuticular sutures using non-absorbable polypropylene after elective cesarean section

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interrupted subcuticular skin closure

skin is closed with interrupted mattress subcuticular sutures using non-absorbable polypropylene after elective cesarean section

Intervention Type PROCEDURE

continuous subcuticular skin closure

skin is closed with continuous subcuticular sutures using non-absorbable polypropylene after elective cesarean section

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* Overall good health
* Elective Cesarean section ASA class 1 or 2

Exclusion Criteria

* Allergy to synthetic suture materials
* Diabetes whether gestational or pregestational
* use of steroid or immunosuppresive medication within last 6 month of procedure
* Skin sepsis or systemic fever
* BMI \> 35
* History of keloid or hypertrophic scar formation or dermatologic conditions known to impair wound healing ASA class 3 or 4
Minimum Eligible Age

19 Years

Maximum Eligible Age

39 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed M Maged, MD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmed Maged, MD

Role: PRINCIPAL_INVESTIGATOR

Kasr Alainy medical school

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kasr Alainy medical school

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

167

Identifier Type: -

Identifier Source: org_study_id